[Effect of estrogen and progesterone on the expression of VEGF mRNA in epithelial ovarian cancer cell line]

Zhonghua Zhong Liu Za Zhi. 2004 May;26(5):264-7.
[Article in Chinese]

Abstract

Objective: To study the effect of 17beta-estradiol (17beta-E(2)) and medroxyprogesterone acetate (MPA) on the expression of VEGF mRNA in epithelial ovarian carcinoma cell line in vitro.

Methods: Human epithelial ovarian carcinoma cell line SKOV3 cells were exposed to 17beta-E(2) (10(-12) approximately 10(-8) mol/L) or MPA (10(-9) approximately 10(-5) mol/L), the expression level of VEGF mRNA was determined by RT-PCR.

Results: The PCR products of VEGF were mainly 606 bp and 474 bp. The expression of VEGF mRNA in the 17beta-E(2)-treated cells was significantly higher than in the untreated control (P < 0.05), the expression level of VEGF mRNA increased with the increase in 17beta-E(2) concentration. The expression of VEGF mRNA in SKOV3 cells treated with MPA (10(-9) approximately 10(-5) mol/L) was significantly lower than in the untreated control (P < 0.05), especially that of 606 bp.

Conclusion: Estrogen can up-regulate, while progesterone can down-regulate mRNA expression of VEGF. Further studies are needed to elucidate the mechanism.

Publication types

  • English Abstract

MeSH terms

  • Adenocarcinoma / metabolism
  • Adenocarcinoma / pathology
  • Antineoplastic Agents, Hormonal / pharmacology*
  • Cell Line, Tumor
  • Dose-Response Relationship, Drug
  • Estradiol / pharmacology*
  • Female
  • Humans
  • Medroxyprogesterone Acetate / pharmacology*
  • Ovarian Neoplasms / metabolism*
  • Ovarian Neoplasms / pathology
  • RNA, Messenger / biosynthesis
  • RNA, Messenger / genetics
  • Vascular Endothelial Growth Factor A / biosynthesis*
  • Vascular Endothelial Growth Factor A / genetics

Substances

  • Antineoplastic Agents, Hormonal
  • RNA, Messenger
  • Vascular Endothelial Growth Factor A
  • Estradiol
  • Medroxyprogesterone Acetate